An inspiring clinical trial from the University of Calgary has revealed that high-dose Vitamin B3, also known as niacin, could become a powerful tool against glioblastoma, one of the deadliest forms of brain cancer. The study showed that an incredible 82% of patients remained progression-free after six months of treatment. Researchers discovered that the vitamin successfully revives internal immune cells that are normally suppressed by the tumor, allowing the body’s natural defenses to fight back. While larger confirmation trials are still required, this represents a massive milestone in oncology.
About the Author
